What You Should Know:
– Medable Inc., a leader in modern clinical trial technology, has announced a groundbreaking partnership with Masimo (NASDAQ: MASI) to integrate medical-grade wearable devices into clinical research. This collaboration aims to…
Continue Reading
What You Should Know:
– Sanofi, a global pharmaceutical leader, Formation Bio, an AI-powered drug developer, and OpenAI, a leading research and development company in artificial intelligence, have announced a groundbreaking collaboration. The first-of-its-kind partnership…
Continue Reading
Digital health technologies (DHTs) have the potential to modernize drug development and clinical trial operations by remotely, passively, and continuously collecting ecologically valid evidence that is meaningful to patients’ lived experiences. Such evidence holds…
Continue Reading
What You Should Know:
– Accenture Ventures, the venture capital arm of Accenture, has announced a strategic investment in Turbine, a company pioneering the use of predictive cell simulations for drug development.
– The investment aims…
Continue Reading
The rise of AI-powered health tech for managing administrative tasks to identifying targets for drug development, the push towards value-based care adoption, the adoption of telehealth to facilitate access to care, have helped drive…
Continue Reading
Health technology assessment (HTA) is a formidable task across drug development, medical device innovation, and digital health solutions. To help with this task, the European HTA Regulation entered into force in January 2022 and will apply…
Continue Reading
What You Should Know; – Boston Micro Fabrication (BMF) today announced the launch of BMF Biotechnology Inc., a dedicated subsidiary focused on developing and commercializing innovative BioChips – advanced microfluidic platforms that mimic human…
Continue Reading
What You Should Know:
– ARC Innovation, the innovation arm of Sheba Medical Center, Israel’s leading medical center and a six-time Newsweek World’s Best Hospital awardee, today announced its participation in the Trustworthy & Responsible…
Continue Reading
What You Should Know:
– BioPhy, an AI drug development company, and Every Cure, a non-profit dedicated to unlocking the potential of existing drugs for new uses, today announced a strategic partnership to revolutionize drug…
Continue Reading
What You Should Know:
– Genomics plc, a leader in polygenic risk score (PRS) technology, and pharmaceutical giant GSK inks a new collaboration to explore the potential of PRS for optimizing clinical trial design.
– The…
Continue Reading
